All Content Clinical Leader

  1. What Is Win Ratio, And How Can It Be Used In Rare Disease Research? 12/17/2025

    Amber Salzman, CEO of Epicrispr Biotechnologies, explains how applying the win ratio in facioscapulohumeral muscular dystrophy (FSHD) could transform the way researchers evaluate therapeutic impact, enhance statistical efficiency, and improve trial design.

  2. More 2026 Clinical Predictions 12/17/2025

    Part 2 of this 2026 forecast series dives deeper into the operational friction points the clinical trials industry still hasn’t resolved. Industry leaders weigh in on sponsor–site partnerships under strain, the growing tech burden on sites, consolidation across site networks and platforms, the limits of AI hype, and why human connection may end up being the most important “innovation” of all.

  3. Adaptive Trial Design Is Changing Oncology And Hematology Clinical Trials 12/16/2025

    Pfizer Global Development Lead, Clinical Development Oncology & Hematology, Shreya Badhrinarayanan, MD, explains how adaptive trials, enriched by AI and better data integration, are transforming oncology and hematology clinical research.

  4. Poland: An Underestimated Clinical Trials Powerhouse 12/15/2025

    Poland is not “one of the good options” or “an interesting emerging market," says Tomasz Szelag, head of clinical operations, Ryvu Therapeutics. Rather, it should be one of the first places sponsors look to run their clinical trials.

  5. 2026 Forecasts From People Smarter Than Me – Part 1 12/12/2025

    In Part 1 of this forecast series, leaders from TransCelerate, Genentech, Clinical Performance Partners, Marketcap Consulting, and others weigh in on what’s coming next — from regulatory pressure and RBQM mandates to BYOT momentum, AI reality checks, and the financial rebound many CROs are betting on.

  6. Can't-Miss Advice On Selecting Your First AI-Enabled Vendor 12/12/2025

    Quarles & Brady's Simone Colgan Dunlap and Meghan O’Connor offer actionable guidance to help sponsor companies make informed, strategic choices in an evolving AI market.

  7. Expanding Clinical Research In East Africa With Digital Innovation 12/11/2025

    Africa carries 25% of the world’s disease burden but hosts only 1% of clinical trials. Discover technology-driven strategies that close this gap and transform research access in underserved regions.

  8. Lindus Health And Quotient Sciences Partner To Accelerate Drug Development From First-In-Human To Pivotal Trials 12/11/2025

    Lindus Health and Quotient Sciences partnership combines Quotient's specialized early clinical and drug development capabilities with Lindus’ proven patient recruitment expertise and later-stage trial delivery.

  9. Clinical Supply's Role In Driving Success In Decentralized Trials 12/11/2025

    Decentralized trials are a challenge for supply chain professionals. Explore how logistics, labeling, and home delivery make or break trial outcomes.

  10. The 2020 Pediatric Mandate That Shook Up Oncology Research 12/11/2025

    Until 2020, the majority of drugs used in pediatric medicine had not been studied adequately in children. Regulatory expert Bhargavi Pandit recounts the impact the U.S. RACE for Children Act had on pediatric and adult investigational drug trials.